American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
SINOVAC BIOTECH LTD
$386.0MRevenue · FY2025
-$13.5MNet income
2,643Employees
SVANASDAQ
2003IPO
About SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its products include vaccines for hepatitis A, hepatitis B, EV-A71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella, mumps, and tetanus. The Company generates maximum revenue from Mainland China.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $386.0M
- Net income
- -$13.5M
- Total assets
- $8.5B
Source: SEC EDGAR · updated Jun 8, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 26, 2003
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review SINOVAC BIOTECH LTD.
Write a review
Explore
Browse all →
